Division of
GMP Publications, Inc.

ohn Cuspilich
Send Comments to QA/RA Editor

Food and Drug Assistance - Resources for Industry and Consumers

 

 

 
 

Condition - Disease

Links & Resources

- Add an Forum -

Acne - see Skin Care

ADD and ADHD

AIDS/HIV

Allergies

Alzheimer's

Arthritis

Asthma

Autism

Back Pain

Birth Control

Cancer - Breast

Cancer - Prostate

Cholesterol

Common Cold  |  Flu

Crohn's & Colitis

Dental Health

Diabetes

Diet & Nutrition

Ear Disorders

Epilepsy

Erectile Dysfunction

Hair Loss

HeadacheMigraine

Heartburn

Heart Attacks

Hepatitis

Hemorrhoids

Kidney

Lyme Disease

Men's Health

MRSA

Multiple Sclerosis

Osteoporosis

Parkinson's

SARS

SIDS

Skin Care

Sleep Disorders

Smoking

Snoring

Stress | Depression

Stroke

Vitamins

Weight Control


 
Prostate Cancer

Clinical Trials  |  Add a link  |  Regulations  |  Discussion Board  |  Ask the Nurse | Last Update January 1st. 2009  |  About FDA.COM  | Media Kit


The prostate is the gland below a man's bladder that produces fluid for semen. Prostate cancer is the third most common cause of death from cancer in men of all ages. It is rare in men younger than 40.

Levels of a substance called prostate specific antigen (PSA) is often high in men with prostate cancer. However, PSA can also be high with other prostate conditions. Since the PSA test became common, most prostate cancers are found before they cause symptoms. Symptoms of prostate cancer may include

  • Problems passing urine, such as pain, difficulty starting or stopping the stream, or dribbling
  • Low back pain
  • Pain with ejaculation

Prostate cancer treatment often depends on the stage of the cancer. How fast the cancer grows and how different it is from surrounding tissue helps determine the stage. Treatment may include surgery, radiation therapy, chemotherapy or control of hormones that affect the cancer.

Start Here
 

 

Also see 'Cancer'

Reference Links - Add a link

 

Clinical Trials - Add a clinical trial

 top
1
Recruiting
Prostate Cancer - Qatar
Condition:
Prostate Cancer 
Intervention:
 
 
 

 
2
Recruiting
Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer Screening
Condition:
Prostate Cancer 
Intervention:
Behavioral: Educational Intervention to Increase Informed Decision Making for Prostate Cancer Screening 
 
 

 
3
Not yet recruiting
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: GVAX prostate cancer vaccine;   Drug: bicalutamide;   Drug: goserelin;   Drug: leuprolide acetate 
 
 

 
4
Recruiting
Long-Term Follow-Up Study of Patients Who Were Diagnosed With Prostate Cancer While Undergoing Treatment on a Prostate Cancer Prevention Trial
Condition:
Prostate Cancer 
Interventions:
Procedure: observation;   Procedure: quality-of-life assessment 
 
 

 
5
Recruiting
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Conditions:
Prostate Cancer;   Prostatic Cancer;   Prostate Neoplasms;   Prostatic Neoplasms;   Cancer of the Prostate 
Intervention:
Radiation: CyberKnife Stereotactic Radiosurgery 
 
 

 
6
Recruiting
Genetic and Environmental Risk Factors in African American and Caucasian Healthy Men and in Patients With Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Procedure: evaluation of cancer risk factors;   Procedure: gene expression analysis;   Procedure: molecular genetic technique;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables 
 
 

 
7
Recruiting
Coping in African American Prostate Cancer Survivors
Condition:
Prostate Cancer 
Interventions:
Behavioral: Coping Skills Training;   Behavioral: Prostate Cancer Education 
 
 

 
8
Recruiting
A Study to Test the Safety & Effectiveness of Docetaxel With RAD001 & Bevacizumab in Men With Advanced Prostate Cancer
Condition:
Prostate Cancer 
Intervention:
Drug: RAD001, Docetaxel, Bevacizumab 
 
 

 
9
Recruiting
Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Watchful Waiting
Condition:
Prostate Cancer 
Interventions:
Procedure: biopsy;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: imaging biomarker analysis;   Procedure: magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging;   Procedure: observation 
 
 

 
10
Recruiting
Internet-Based Education for Prostate Cancer Screening
Condition:
Prostate Cancer 
Interventions:
Behavioral: educational internet site on prostate cancer screening;   Behavioral: Educational print booklet;   Behavioral: Usual care 
 
 

 
11
Recruiting
Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound (HIFU)
Condition:
Prostate Cancer 
Intervention:
Device: High Intensity Focused Ultrasound 
 
 

 
 
13
Recruiting
Clinico-Pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer
Condition:
Prostate Cancer 
Intervention:
Device: Magnetic Resonance Spectroscopy (3Tesla) 
 
 

 
14
Recruiting
Study of Anxiety in African American Men With Prostate Cancer
Conditions:
Cancer-Related Problem/Condition;   Prostate Cancer 
Interventions:
Procedure: medical chart review;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment;   Procedure: questionnaire administration 
 
 

 
15
Recruiting
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: docetaxel;   Drug: goserelin;   Drug: leuprolide acetate;   Procedure: conventional surgery 
 
 

 
16
Recruiting
 

 
17
Recruiting
Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: dutasteride;   Drug: placebo 
 
 

 
18
Recruiting
Selenium in Treating Patients With Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: placebo;   Drug: selenium 
 
 

 
19
Recruiting
Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia
Condition:
Prostate Cancer 
Interventions:
Drug: dutasteride;   Procedure: prostate biopsy 
 
 

 
20
Recruiting
Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: BCG vaccine;   Drug: placebo;   Drug: prostate cancer vaccine ONY-P1 
 
 

 
21
Recruiting
Low-Fat Fish Oil Diet for Prostate Cancer Prevention
Condition:
Prostate Cancer 
Interventions:
Dietary Supplement: Fish Oil;   Dietary Supplement: Vitamin E supplement;   Dietary Supplement: Western Diet;   Dietary Supplement: Low-Fat Diet;   Other: Medical Examination;   Other: Dietary Interview;   Other: Blood Draw;   Procedure: Radical Prostatectomy 
 
 

 
22
Recruiting
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
Condition:
Prostate Cancer 
Interventions:
Drug: bicalutamide;   Drug: docetaxel;   Drug: flutamide;   Drug: goserelin;   Drug: leuprolide acetate;   Procedure: 3-dimensional conformal radiation therapy;   Procedure: adjuvant therapy;   Procedure: intensity-modulated radiation therapy 
 
 

 
23
Recruiting
Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: cyproterone acetate;   Procedure: hypofractionated radiation therapy;   Procedure: intensity-modulated radiation therapy;   Procedure: releasing hormone agonist therapy 
 
 

 
24
Recruiting
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Conditions:
Prostate Cancer;   Prostatic Cancer;   Prostatic Neoplasms;   Prostate Neoplasms;   Cancer of the Prostate 
Intervention:
Radiation: CyberKnife Stereotactic Radiosurgery 
 
 

 
25
Recruiting
Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer
Condition:
Prostate Cancer 
Intervention:
Biological: OGX-011 
 
 

 
26
Not yet recruiting
Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases
Conditions:
Metastatic Cancer;   Prostate Cancer 
Interventions:
Drug: paricalcitol;   Procedure: dual x-ray absorptometry;   Procedure: immunoenzyme technique;   Procedure: laboratory biomarker analysis 
 
 

 
27
Recruiting
Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
Condition:
Prostate Cancer 
Intervention:
Drug: Transdermal Estradiol 
 
 

 
28
Recruiting
Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men
Condition:
Prostate Cancer 
Interventions:
Procedure: evaluation of cancer risk factors;   Procedure: mutation carrier screening;   Procedure: physiologic testing;   Procedure: study of high risk factors;   Procedure: study of socioeconomic and demographic variables 
 
 

 
29
Recruiting
Gene Therapy for Prostate Cancer That Returns After Radiation Therapy
Conditions:
Prostatic Neoplasms;   Neoplasm Recurrence, Local 
Intervention:
Gene Transfer: Ad.hIL-12 
 
 

 
30
Recruiting
MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer
Condition:
Prostate Cancer 
Intervention:
Procedure: MRI Targeted Focal Thermal Therapy of Prostate Cancer 
 
 

 
31
Recruiting
Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
Conditions:
Prostate Cancer;   Adenocarcinoma of the Prostate 
Interventions:
Drug: Bevacizumab;   Drug: Docetaxel 
 
 

 
32
Recruiting
MRI/MRSI in Risk Assessment of Prostate Cancer Patients
Condition:
Prostate Cancer 
Intervention:
Other: eMRI/MRSI 
 
 

 
33
Recruiting
Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: Docetaxel;   Drug: Carboplatin 
 
 

 
34
Recruiting
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: docetaxel;   Procedure: adjuvant therapy;   Procedure: observation 
 
 

 
35
Recruiting
CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: Bicalutamide and CP-675,206 (Tremelimumab);   Drug: Bicalutamide, CP-675,206 (tremelimumab);   Drug: Bicalutamide, CP-675,206 (Tremelimumab);   Drug: Bicalutamide, CP-675,206 (Tremelimumab);   Drug: Bicalutamide, CP-675,206 
 
 

 
36
Recruiting
Active Surveillance in Prostate Cancer
Condition:
Prostate Cancer 
Intervention:
Behavioral: Survey 
 
 

 
37
Recruiting
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: goserelin;   Procedure: adjuvant therapy;   Procedure: radiation therapy 
 
 

 
38
Recruiting
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older
Condition:
Prostate Cancer 
Interventions:
Behavioral: Questionaires;   Behavioral: Questionaires 
 
 

 
39
Recruiting
RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: RAD001;   Drug: Bicalutamide 
 
 

 
40
Recruiting
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: bicalutamide;   Drug: buserelin;   Drug: docetaxel;   Drug: flutamide;   Drug: goserelin;   Drug: leuprolide acetate;   Drug: prednisone;   Drug: triptorelin;   Procedure: radiation therapy 
 
 

 
41
Recruiting
Hormone Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
Conditions:
Cancer-Related Problem/Condition;   Prostate Cancer 
Interventions:
Drug: transdermal estrogen;   Procedure: releasing hormone agonist therapy 
 
 

 
42
Recruiting
Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Procedure: quality-of-life assessment;   Procedure: questionnaire administration;   Procedure: stereotactic radiosurgery 
 
 

 
43
Recruiting
Androgen Suppression Alone or Combined With Zoledronate, Docetaxel, Prednisolone, and/or Celecoxib in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: celecoxib;   Drug: docetaxel;   Drug: prednisolone;   Drug: zoledronic acid;   Procedure: orchiectomy;   Procedure: releasing hormone agonist therapy 
 
 

 
44
Recruiting
 

 
45
Recruiting
Ketoconazole, Hydrocortisone, and Lenalidomide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Condition:
Prostate Cancer 
Interventions:
Drug: ketoconazole;   Drug: lenalidomide;   Drug: therapeutic hydrocortisone;   Procedure: flow cytometry;   Procedure: immunoenzyme technique;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: polymerase chain reaction 
 
 

 
46
Recruiting
Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer
Condition:
Prostate Cancer 
Interventions:
Drug: docetaxel;   Procedure: biopsy;   Procedure: conventional surgery;   Procedure: laboratory biomarker analysis;   Procedure: neoadjuvant therapy;   Procedure: radiation therapy 
 
 

 
47
Recruiting
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
Conditions:
Pain;   Prostate Cancer 
Interventions:
Drug: docetaxel;   Procedure: releasing hormone agonist therapy 
 
 

 
48
Recruiting
A Phase I/II Study of HE3235 in Patients With Prostate Cancer
Condition:
Prostate Cancer 
Intervention:
Drug: HE3235 
 
 

 
49
Recruiting
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
Conditions:
Prostatic Diseases;   Genital Neoplasms, Male;   Urogenital Neoplasms;   Genital Diseases, Male;   Adenocarcinoma;   Prostatic Neoplasms;   Neoplasms, Glandular and Epithelial;   Carcinoma 
Intervention:
Drug: Ixabepilone 
 
 

 
50
Recruiting
A Phase III Trial of ZD4054 (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases
Condition:
Prostate Cancer 
Interventions:
Drug: ZD4054;   Other: Best supportive care